Diebold Nixdorf (DBD) Misses Q4 EPS by 47c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.18 -2.17%
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Net income attributable to Diebold, Incorporated: -21.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $0.97, $0.47 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $988.9 million versus the consensus estimate of $1.03 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Explosions heard on Iran's Kharg island - MEHR
- Jefferies: 'we can still see at least a +25-50% stock move if SRPT shows competitive/superior 6-month splicing/vHOT data'
- Ramp In Talks For New Funding At $60 Billion Valuation - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
